Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-17

Clinical Trial Update: Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics [Phase 3]

View source ↗

Summary

Phase 3 trial assessing tapentadol hydrochloride for effectiveness and tolerability in adults with severe chronic low back pain on various analgesic regimens; s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tapentadol hydrochloride (Tapentadol hydrochloride)

Snippet

Sponsor: Grünenthal GmbH | Conditions: Chronic Pain, Low Back Pain | Phase 3 | Status: COMPLETED | Results posted: 2012-04-17